James Wang
Exampled by winning NMPA approval of Inaticabtagene Autoleucel (CNCT19)-the CAR-T cell therapy for adult r/r B-ALL treatment, dedicated... | Princeton, New Jersey, United States
*50 free lookup(s) per month.
No credit card required.
James Wang’s Emails ja****@no****.com
James Wang’s Phone Numbers No phone number available.
Social Media
James Wang’s Location Princeton, New Jersey, United States
James Wang’s Expertise Exampled by winning NMPA approval of Inaticabtagene Autoleucel (CNCT19)-the CAR-T cell therapy for adult r/r B-ALL treatment, dedicated to developing affordable and accessible therapies for unmet clinical needs. Over 15-year hands-on technical and leadership experiences in cell therapy, including process development (PD), CMC, GMP manufacturing, QMS setup, IND and NDA filing, and product launch and commercialization. Teambuilding and operation establishment in 3 start-ups, experience of big MNC pharma culture. Upbeat, open, positive, energetic, strategic, analytical thinking, and effective leadership, love to make things happen. Proud of pioneering clinical research at MSKCC demonstrating the safety and efficacy of CD19 CAR-T cell therapy in treating adult r/r ALL cancer disease. Participated and witnessed the entire journey of CAR-T cell therapy from early clinical research & development, clinical trial, to commercial launching including implementation in hospitals worldwide. Passionate of the cutting-edge and life-saving cell therapies hallmarked by CAR-T technology (bit.ly/Next_Frontier), (bit.ly/Longest_CAR-T) and (bit.ly/Kymriah_Approval) , chasing a dream of universal on-the-shelf in-vivo cell therapies that are affordable and accessible for any patients in needs. Experiences: * From clinical research to commercialization * Cell therapy manufacturing process development * Clinical GMP manufacturing and commercial readiness * Cell therapy IND and NDA CMC filing * Cell therapy quality management and operation * Talents recruting and team building * Strategic planning and effective leadership
James Wang’s Current Industry Juventas Cell Therapy
James
Wang’s Prior Industry
Genscript
|
Vivaldi Biosciences
|
Memorial Sloan Kettering Cancer Center
|
Novartis
|
Juventas Cell Therapy
Not the James Wang you were looking for?
Find accurate emails & phone numbers for over 700M professionals.
Work Experience
Juventas Cell Therapy
Chief Technology Officer (CTO)
Fri Jan 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) — Present
Novartis
Global Quality Auditor / Cell & Gene Therapy
Sun Apr 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Dec 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Memorial Sloan Kettering Cancer Center
Sr QA Manager / Cell Therapy & Cell Engineering
Wed Oct 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Mar 01 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Memorial Sloan Kettering Cancer Center
QA Coordinator / Gene Transfer & Cell Engineering
Mon Aug 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Sep 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Vivaldi Biosciences
Manager / GMP Production
Fri Aug 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Aug 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Genscript
Supervisor / QC Scientist
Thu Mar 01 2007 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Jul 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time)Skills
Languages
James Wang Email Addresses
FAQ About James Wang
-
James Wang is located at
Princeton, New Jersey, United States -
James Wang is a
Exampled by winning NMPA approval of Inaticabtagene Autoleucel (CNCT19)-the CAR-T cell therapy for adult r/r B-ALL treatment, dedicated to developing affordable and accessible therapies for unmet clinical needs. Over 15-year hands-on technical and leadership experiences in cell therapy, including process development (PD), CMC, GMP manufacturing, QMS setup, IND and NDA filing, and product launch and commercialization. Teambuilding and operation establishment in 3 start-ups, experience of big MNC pharma culture. Upbeat, open, positive, energetic, strategic, analytical thinking, and effective leadership, love to make things happen. Proud of pioneering clinical research at MSKCC demonstrating the safety and efficacy of CD19 CAR-T cell therapy in treating adult r/r ALL cancer disease. Participated and witnessed the entire journey of CAR-T cell therapy from early clinical research & development, clinical trial, to commercial launching including implementation in hospitals worldwide. Passionate of the cutting-edge and life-saving cell therapies hallmarked by CAR-T technology (bit.ly/Next_Frontier), (bit.ly/Longest_CAR-T) and (bit.ly/Kymriah_Approval) , chasing a dream of universal on-the-shelf in-vivo cell therapies that are affordable and accessible for any patients in needs. Experiences: * From clinical research to commercialization * Cell therapy manufacturing process development * Clinical GMP manufacturing and commercial readiness * Cell therapy IND and NDA CMC filing * Cell therapy quality management and operation * Talents recruting and team building * Strategic planning and effective leadership Juventas Cell Therapy -
James Wang currently works in the
Juventas Cell Therapy -
James Wang specializes in
Exampled by winning NMPA approval of Inaticabtagene Autoleucel (CNCT19)-the CAR-T cell therapy for adult r/r B-ALL treatment, dedicated to developing affordable and accessible therapies for unmet clinical needs. Over 15-year hands-on technical and leadership experiences in cell therapy, including process development (PD), CMC, GMP manufacturing, QMS setup, IND and NDA filing, and product launch and commercialization. Teambuilding and operation establishment in 3 start-ups, experience of big MNC pharma culture. Upbeat, open, positive, energetic, strategic, analytical thinking, and effective leadership, love to make things happen. Proud of pioneering clinical research at MSKCC demonstrating the safety and efficacy of CD19 CAR-T cell therapy in treating adult r/r ALL cancer disease. Participated and witnessed the entire journey of CAR-T cell therapy from early clinical research & development, clinical trial, to commercial launching including implementation in hospitals worldwide. Passionate of the cutting-edge and life-saving cell therapies hallmarked by CAR-T technology (bit.ly/Next_Frontier), (bit.ly/Longest_CAR-T) and (bit.ly/Kymriah_Approval) , chasing a dream of universal on-the-shelf in-vivo cell therapies that are affordable and accessible for any patients in needs. Experiences: * From clinical research to commercialization * Cell therapy manufacturing process development * Clinical GMP manufacturing and commercial readiness * Cell therapy IND and NDA CMC filing * Cell therapy quality management and operation * Talents recruting and team building * Strategic planning and effective leadership -
James Wang speaks the following languages:
No languages available. -
James Wang has prior experience in the following industries:
Novartis , Memorial Sloan Kettering Cancer Center , Memorial Sloan Kettering Cancer Center , Vivaldi Biosciences , Genscript -
James Wang has the following professional experience:
Juventas Cell Therapy , Novartis , Memorial Sloan Kettering Cancer Center , Memorial Sloan Kettering Cancer Center , Vivaldi Biosciences , Genscript . -
You can view James Wang’s
LinkedIn profile at LinkedIn URL. -
James Wang’s work email addresses are
[email protected] . -
James Wang works at
Juventas Cell Therapy
People you may be interested in
- Benoit Daussy
- Cogne Michael
- Julie Matrat
- Diana Carrillo
- Gerhard Enslin
- Elena Boti
Co-Fondateur // Responsable Production
Research & Development Manager by Michelin
Chief Executive Officer
RBT | BA
Industrial Property Broker at Bond Street Property Solutions
Assistant General Manager